Palvella Therapeutics (PVLA) Receivables - Net (2013 - 2024)

Palvella Therapeutics (PVLA) has 11 years of Receivables - Net data on file, last reported at $358000.0 in Q4 2024.

• Quarterly Receivables - Net changed N/A year-over-year to $358000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $358000.0 (changed N/A YoY) and the FY2024 annual result came in at $358000.0, changed N/A from the prior year.
• Receivables - Net eased to $358000.0 in Q4 2024 per PVLA's latest filing, from $373000.0 in the prior quarter.
• Across five years, Receivables - Net topped out at $17.0 million in Q2 2021 and bottomed at $358000.0 in Q4 2024.
• The 5-year median for Receivables - Net is $1.7 million (2020), against an average of $4.9 million.
• The widest annual swing landed in 2021, when Receivables - Net surged 477.45%; it then slumped 95.12% in 2022.
• Tracing PVLA's Receivables - Net over 5 years: stood at $1.7 million in 2020, then jumped by 94.2% to $3.3 million in 2021, then soared by 75.37% to $5.8 million in 2022, then tumbled by 82.01% to $1.0 million in 2023, then plunged by 65.74% to $358000.0 in 2024.
• Per Business Quant, the three latest PVLA Receivables - Net figures stand at $358000.0 (Q4 2024), $373000.0 (Q3 2024), and $1.5 million (Q2 2024).

Peer Comparison